Question Why are Medical Cannabinoid Treatments not legal for Drs to prescribe now ?

Jul 2, 2020
Who is stopping the medical research ?

Why isnt the US Government funding human trials ?

How to fast track medical use of cannabinoids ?

More Government info links on the medical use of cannabinoids later belew

Medical Cannabinoids are not designed for recreational purposes or effects, are typically extracted as oil, are medically tested and licenced and seek different properties to those used in recreational use of cannabis.

The link below is by a lady who made her own docu showing how cannabinoid oils shrunk her tumor by 50% when the Drs said there was no more they could do. Plus she had her cancer Drs do all the blood works every three weeks and continue to monitor her.

Here is the docu which is well done


Here is her web site

The US Government has known for many years that there is very strong evidence from animal trials that cannabinoids are almost certainly very effective treatments for a range of conditions including a wide range of cancers - at least from the 1990s onwards and the 1972 US Govt Shafer Commission made very clear that there were medical benefits that should be researched. Much of the research is not easily found in searches even when quoting directly from the documents. I have also noticed that many different old links on cannabinoid research or US Govt research links now all go back to a central government page about cannabinoids and not the research itself

In 1988 US Courts ruled to allow medical research and reschedule cannabinoids. The DEA over ruled these decisions. See page 4 of Brookings
Institute Report link below.

Also note the DEA in 1980 was ordered by the US Courts to carry out scientific research into the medical benefits - it is unclear what was done

1972 US Government Shafer Commission Report found Cannabis had a wide range of medical benefits and should be medically researched.
(US government rejected these findings and sai there was no medical use)

Copy of the Shafer Report

Antitumor Effects

One study in mice and rats suggested that cannabinoids may have a protective effect against the development of certain types of tumors.[3] During this 2-year study, groups of mice and rats were given various doses of THC by gavage. A dose-related decrease in the incidence of hepatic adenoma tumors and hepatocellular carcinoma (HCC) was observed in the mice. Decreased incidences of benign tumors (polyps and adenomas) in other organs (mammary gland, uterus, pituitary, testis, and pancreas) were also noted in the rats. In another study, delta-9-THC, delta-8-THC, and cannabinol were found to inhibit the growth of Lewis lung adenocarcinoma cells in vitro and in vivo.[4] In addition, other tumors have been shown to be sensitive to cannabinoid-induced growth inhibition.[5-8]

Cannabinoid pharmacology has made important advances in recent years after the discovery of the cannabinoid receptors. These discoveries have added to our understanding of exogenous and endogenous cannabinoid signaling along with exploring the various pathways of their biosynthesis, molecular structure, inactivation, and anatomical distribution of their receptors throughout the body. The endocannabinoid system is involved in immunoregulation and neuroprotection. In this article, we have reviewed the possible mechanisms of the regulation of the immune response by endocannabinoids which include modulation of immune response in different cell types, effect on cytokine network, induction of apoptosis in immune cells and downregulation of innate and adaptive immune response. Studies from our laboratory have suggested that administration of endocannabinoids or use of inhibitors of enzymes that breakdown the endocannabinoids, leads to immunosuppression and recovery from immune-mediated injury to organs such as the liver. Thus, manipulation of endocannabinoids in vivo may constitute a novel treatment modality against inflammatory disorders.

a large body of evidence shows that these molecules can decrease tumour growth in animal models of cancer. They do so by modulating key cell signalling pathways involved in the control of cancer cell proliferation and survival. In addition, cannabinoids inhibit angiogenesis and decrease metastasis in various tumour types in laboratory animals. In this review, we discuss the current understanding of cannabinoids as antitumour agents, focusing on recent discoveries about their molecular mechanisms of action, including resistance mechanisms and opportunities for their use in combination therapy. Those observations have already contributed to the foundation for the development of the first clinical studies that will analyze the safety and potential clinical benefit of cannabinoids as anticancer agents.
Last edited: